Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 13, 2013 - Issue 2: Monoclonal Antibodies
Submit an article Journal homepage
451
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Ipilimumab in prostate cancer

Nishith SinghNational Cancer Institute, National Institutes of Health, Center for Cancer Research, Medical Oncology Branch, Laboratory of Tumor Immunology and Biology, Bethesda, MD 20892, USA+1 301 435 2956; +1 301 480 5094; [email protected]
,
Ravi A MadanNational Cancer Institute, National Institutes of Health, Center for Cancer Research, Medical Oncology Branch, Laboratory of Tumor Immunology and Biology, Bethesda, MD 20892, USA+1 301 435 2956; +1 301 480 5094; [email protected]
&
James L GulleyNational Cancer Institute, National Institutes of Health, Center for Cancer Research, Medical Oncology Branch, Laboratory of Tumor Immunology and Biology, Bethesda, MD 20892, USA+1 301 435 2956; +1 301 480 5094; [email protected]
Pages 303-313 | Published online: 25 Dec 2012

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jonathan PH Fisher, Jennifer Heuijerjans, Mengyong Yan, Kenth Gustafsson & John Anderson. (2014) γδ T cells for cancer immunotherapy. OncoImmunology 3:1.
Read now
Gianfranco Baronzio, Gurdev Parmar, Irina ZH Shubina, Valter Cassutti, Sergio Giuli, Marco Ballerini & Mikhail Kiselevsky. (2013) Update on the challenges and recent advances in cancer immunotherapy. ImmunoTargets and Therapy 2, pages 39-49.
Read now

Articles from other publishers (3)

Zhen Kang, Jiang-Bo Sun, Fei Lin, Xu-Yun Huang, Qi Huang, Dong-Ning Chen, Qing-Shui Zheng, Xue-Yi Xue, Ning Xu & Yong Wei. (2023) Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer. Frontiers in Oncology 13.
Crossref
Margaret K. Callahan & Jedd D. Wolchok. (2015) Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists. Seminars in Oncology 42:4, pages 573-586.
Crossref
Nishith Singh, Ravi Madan & James L Gulley. (2013) Novel immunotherapeutic agents for castration-resistant prostate cancer: update from clinical trials. Clinical Investigation 3:7, pages 651-663.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.